URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Jonathan Friedberg

Concepts (449)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Antineoplastic Combined Chemotherapy Protocols
41
1999
429
9.580
Why?
Lymphoma, Non-Hodgkin
26
1999
113
9.210
Why?
Lymphoma, Large B-Cell, Diffuse
20
1999
78
8.280
Why?
Lymphoma, Follicular
18
1999
54
7.820
Why?
Antibodies, Monoclonal
31
2002
711
7.170
Why?
Antineoplastic Agents
26
2000
619
6.270
Why?
Antibodies, Monoclonal, Murine-Derived
35
2002
114
6.110
Why?
Hodgkin Disease
15
2002
155
3.990
Why?
Lymphoma, B-Cell
11
1999
62
3.970
Why?
Nitrogen Mustard Compounds
10
2007
20
3.560
Why?
Lymphoma, Mantle-Cell
6
2007
21
2.920
Why?
Lymphoma
8
2003
162
2.650
Why?
Drug Resistance, Neoplasm
10
2005
56
2.450
Why?
Treatment Outcome
31
1999
2615
2.230
Why?
Humans
110
1981
36274
2.220
Why?
Radioimmunotherapy
7
2004
11
2.210
Why?
Salvage Therapy
9
2007
59
2.190
Why?
Combined Modality Therapy
16
1999
486
2.150
Why?
Hematopoietic Stem Cell Transplantation
10
1999
131
1.980
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
4
2004
127
1.770
Why?
Neoplasm Recurrence, Local
8
2001
288
1.770
Why?
Neoplasms, Second Primary
6
1999
125
1.760
Why?
Boronic Acids
6
2007
29
1.760
Why?
Pyrazines
6
2007
33
1.750
Why?
Protein Kinase Inhibitors
3
2009
92
1.620
Why?
Middle Aged
49
1981
9837
1.600
Why?
Clinical Trials as Topic
14
2004
671
1.520
Why?
Oxazines
2
2009
29
1.510
Why?
Pyridines
3
2009
75
1.500
Why?
Adult
46
1981
11351
1.460
Why?
Stem Cell Transplantation
8
2006
110
1.430
Why?
Immunotherapy
5
2000
86
1.420
Why?
Intracellular Signaling Peptides and Proteins
2
2009
138
1.370
Why?
Protein-Tyrosine Kinases
2
2009
170
1.360
Why?
Survival Analysis
14
1998
606
1.290
Why?
Bone Marrow Transplantation
7
1999
197
1.290
Why?
Burkitt Lymphoma
2
2008
52
1.270
Why?
Survival Rate
15
1999
618
1.220
Why?
Aged
33
1981
7269
1.210
Why?
Transplantation, Autologous
13
1999
144
1.210
Why?
Male
48
1993
19675
1.170
Why?
Female
49
1981
19838
1.140
Why?
Doxorubicin
7
2003
107
1.140
Why?
Recurrence
15
1998
691
1.140
Why?
Deoxycytidine
4
2003
28
1.040
Why?
Antigens, CD20
5
2003
22
1.030
Why?
Medical Oncology
3
2008
48
1.020
Why?
Vidarabine
4
2004
26
0.950
Why?
Amifostine
2
2004
27
0.880
Why?
Neoplasm Staging
9
2003
338
0.850
Why?
Disease-Free Survival
11
2000
198
0.840
Why?
Protease Inhibitors
3
2007
40
0.830
Why?
Precursor Cells, B-Lymphoid
1
2012
4
0.830
Why?
Cytoprotection
2
2004
37
0.770
Why?
Antibiotics, Antineoplastic
1
2011
50
0.760
Why?
Histone Deacetylase Inhibitors
4
2010
29
0.760
Why?
Cyclophosphamide
8
1999
174
0.760
Why?
Immunologic Factors
4
2006
66
0.750
Why?
B-Lymphocytes
5
2002
432
0.710
Why?
Heart Neoplasms
1
2009
21
0.700
Why?
Prognosis
9
1999
1083
0.690
Why?
Toll-Like Receptor 9
1
2009
12
0.690
Why?
Heart Atria
1
2009
68
0.680
Why?
Follow-Up Studies
12
2001
1855
0.670
Why?
Neoplasm Proteins
2
2009
173
0.670
Why?
Gene Expression Profiling
1
2011
301
0.660
Why?
Peripheral Blood Stem Cell Transplantation
2
2003
20
0.650
Why?
Esophageal Neoplasms
1
2009
75
0.650
Why?
Agammaglobulinemia
1
2008
12
0.640
Why?
Oligodeoxyribonucleotides
2
2004
136
0.630
Why?
Cell Differentiation
2
2006
1093
0.630
Why?
B-Lymphocyte Subsets
1
2008
57
0.610
Why?
Tomography, Emission-Computed
2
2003
32
0.580
Why?
Receptors, Tumor Necrosis Factor
1
2008
142
0.580
Why?
Oligopeptides
3
2010
88
0.560
Why?
Lymphocyte Depletion
2
2002
50
0.550
Why?
Immunoglobulin G
1
2008
488
0.530
Why?
Drug Resistance
2
2005
102
0.530
Why?
Aged, 80 and over
11
2002
2529
0.520
Why?
Cohort Studies
6
1999
969
0.500
Why?
Cell Transformation, Neoplastic
2
1999
137
0.490
Why?
Whole-Body Irradiation
2
2001
83
0.490
Why?
Eosinophilia
2
1993
31
0.490
Why?
Clozapine
2
1993
33
0.480
Why?
Antibodies, Neoplasm
3
2008
39
0.480
Why?
Practice Guidelines as Topic
3
2010
302
0.480
Why?
Immunoconjugates
1
2004
9
0.480
Why?
Gallium
1
2004
5
0.480
Why?
Interferon-beta
1
2004
63
0.470
Why?
Interferon-alpha
1
2004
83
0.470
Why?
Tumor Necrosis Factor-alpha
1
2008
659
0.450
Why?
Myelodysplastic Syndromes
2
1999
131
0.450
Why?
Risk Factors
11
1993
2345
0.430
Why?
Vincristine
5
2004
62
0.410
Why?
Pleural Neoplasms
1
2001
18
0.400
Why?
Randomized Controlled Trials as Topic
3
2006
411
0.400
Why?
Tympanoplasty
1
2001
2
0.400
Why?
Mesothelioma
1
2001
30
0.390
Why?
Adenoidectomy
1
2001
11
0.390
Why?
Tonsillectomy
1
2001
15
0.390
Why?
Pneumonia
1
2003
196
0.390
Why?
Prednisone
5
2004
165
0.390
Why?
Interleukin-2
1
2002
198
0.390
Why?
Neoplasms
2
2005
739
0.390
Why?
Lymphoma, B-Cell, Marginal Zone
3
2005
11
0.380
Why?
Guideline Adherence
2
2010
83
0.370
Why?
United States
9
2004
2688
0.370
Why?
Trans-Activators
1
2004
365
0.370
Why?
Thalidomide
2
2010
12
0.370
Why?
Photochemotherapy
1
2001
111
0.370
Why?
Drug Synergism
5
2009
159
0.360
Why?
Proteasome Endopeptidase Complex
2
2008
70
0.360
Why?
Cytarabine
3
2004
89
0.350
Why?
Somatostatin
1
1999
79
0.350
Why?
Drug Administration Schedule
4
2002
366
0.340
Why?
Vinblastine
3
2003
27
0.340
Why?
Antibodies, Monoclonal, Humanized
2
2008
87
0.340
Why?
Sarcoma
1
1999
63
0.330
Why?
Vitamin D
2
2009
71
0.330
Why?
Signal Transduction
6
2005
1567
0.330
Why?
Otitis Media
1
2001
127
0.330
Why?
Ultraviolet Rays
2
2009
199
0.320
Why?
DNA-Binding Proteins
1
2004
685
0.320
Why?
Incidence
6
1993
685
0.320
Why?
Melphalan
2
2004
28
0.320
Why?
Neoplasms, Radiation-Induced
2
2008
80
0.320
Why?
Carmustine
2
2004
37
0.310
Why?
Etoposide
2
2004
83
0.310
Why?
Antidepressive Agents
1
1998
93
0.290
Why?
Depressive Disorder
2
1993
318
0.290
Why?
T-Lymphocytes
3
2002
550
0.280
Why?
Dose-Response Relationship, Drug
4
1999
1117
0.280
Why?
Child
8
1981
4155
0.260
Why?
Retrospective Studies
6
1994
2267
0.260
Why?
Remission Induction
5
2001
161
0.260
Why?
Colitis
1
1995
24
0.260
Why?
Apoptosis
4
2005
823
0.260
Why?
Antineoplastic Agents, Alkylating
3
1999
42
0.260
Why?
Polymerase Chain Reaction
3
1999
596
0.250
Why?
Branchial Region
1
1993
4
0.240
Why?
Diagnostic Imaging
2
2010
87
0.240
Why?
Antibody-Dependent Cell Cytotoxicity
2
2002
28
0.230
Why?
Registries
2
2008
223
0.230
Why?
Bronchi
1
1994
86
0.230
Why?
Trachea
1
1994
68
0.230
Why?
Hydroxamic Acids
2
2010
21
0.230
Why?
Esophagus
1
1994
69
0.230
Why?
Antipsychotic Agents
1
1995
114
0.230
Why?
Foreign Bodies
1
1994
48
0.230
Why?
Kaplan-Meier Estimate
2
2011
222
0.230
Why?
Young Adult
4
2009
1059
0.230
Why?
Extracellular Signal-Regulated MAP Kinases
2
2010
40
0.230
Why?
Flow Cytometry
2
2004
603
0.220
Why?
Psychotic Disorders
1
1993
67
0.220
Why?
Age Factors
3
2001
1128
0.220
Why?
Hospitals, County
1
1992
1
0.220
Why?
Adolescent
8
1981
4766
0.220
Why?
Hospitals, General
1
1992
18
0.220
Why?
Immunophenotyping
3
2002
114
0.210
Why?
Cancer Vaccines
2
2007
33
0.210
Why?
Graft vs Host Disease
2
2002
90
0.210
Why?
Germinal Center
1
2012
15
0.210
Why?
Mitoxantrone
2
2004
20
0.210
Why?
Positron-Emission Tomography
2
2008
39
0.210
Why?
Proto-Oncogene Proteins c-bcl-2
2
2009
116
0.210
Why?
Pyrroles
1
2012
21
0.210
Why?
JNK Mitogen-Activated Protein Kinases
2
2009
95
0.200
Why?
Postoperative Complications
2
2001
733
0.200
Why?
Tumor Microenvironment
1
2011
13
0.200
Why?
Cell Separation
2
2002
231
0.200
Why?
Pneumocystis jirovecii
1
2011
5
0.200
Why?
Central Nervous System Neoplasms
1
2011
22
0.200
Why?
Molecular Targeted Therapy
1
2011
17
0.200
Why?
Hispanic Americans
1
2012
93
0.200
Why?
Methylprednisolone
1
2011
43
0.200
Why?
Gastrointestinal Tract
1
2011
26
0.190
Why?
Interleukin-10
1
2012
104
0.190
Why?
Referral and Consultation
2
1994
196
0.190
Why?
Databases, Factual
1
2012
156
0.190
Why?
Disease Progression
2
2003
521
0.190
Why?
Pancytopenia
1
2010
13
0.190
Why?
Maximum Tolerated Dose
1
2010
17
0.190
Why?
Patient Selection
2
2007
212
0.190
Why?
Infant
5
1981
2278
0.190
Why?
Mucositis
1
2010
13
0.190
Why?
Radiology
1
2011
29
0.190
Why?
Transplantation Conditioning
1
2010
33
0.190
Why?
Acute Disease
2
1993
586
0.190
Why?
Arabinonucleosides
1
2010
2
0.190
Why?
Child, Preschool
6
1981
2660
0.180
Why?
Waldenstrom Macroglobulinemia
1
2010
5
0.180
Why?
Healthcare Disparities
1
2012
77
0.180
Why?
Immunoglobulin kappa-Chains
1
2010
29
0.180
Why?
Genes, Immunoglobulin
1
2010
35
0.180
Why?
Adenine Nucleotides
1
2010
36
0.180
Why?
Immunoglobulin Heavy Chains
1
2010
45
0.180
Why?
Transplantation, Homologous
2
2002
276
0.180
Why?
Pneumonia, Pneumocystis
1
2011
119
0.180
Why?
European Continental Ancestry Group
1
2012
234
0.180
Why?
Esophagogastric Junction
1
2009
9
0.180
Why?
Glucocorticoids
1
2011
162
0.180
Why?
Hematologic Diseases
1
2009
39
0.180
Why?
Diarrhea
1
2009
66
0.180
Why?
MAP Kinase Kinase Kinases
1
2010
42
0.170
Why?
African Americans
1
2012
219
0.170
Why?
Endoscopy, Gastrointestinal
1
2009
26
0.170
Why?
Chemokine CXCL10
1
2009
24
0.170
Why?
Drug Therapy, Combination
2
1999
382
0.170
Why?
Benzopyrans
1
2009
7
0.170
Why?
Comorbidity
2
2005
380
0.170
Why?
Antigens, CD
2
2002
244
0.170
Why?
Forecasting
1
2010
177
0.170
Why?
Platinum Compounds
1
2009
7
0.170
Why?
Fatal Outcome
1
2009
104
0.170
Why?
Vitamin D Deficiency
1
2009
36
0.170
Why?
Multiple Myeloma
1
2010
76
0.170
Why?
Protein Kinase C
1
2011
232
0.170
Why?
Atrial Fibrillation
1
2010
110
0.170
Why?
Nitriles
1
2009
40
0.170
Why?
Predictive Value of Tests
3
2003
606
0.170
Why?
Radiotherapy, Adjuvant
1
2009
73
0.170
Why?
Chemotherapy, Adjuvant
1
2009
88
0.170
Why?
Research Personnel
1
2008
15
0.170
Why?
Phosphatidylinositol 3-Kinases
1
2010
157
0.170
Why?
Daunorubicin
1
2008
25
0.170
Why?
Time Factors
4
2004
3182
0.160
Why?
Cancer Care Facilities
1
2008
11
0.160
Why?
Databases as Topic
1
2008
36
0.160
Why?
SEER Program
1
2009
53
0.160
Why?
Endoplasmic Reticulum
1
2009
94
0.160
Why?
Gene Expression Regulation, Neoplastic
1
2011
256
0.160
Why?
Echocardiography
1
2009
228
0.160
Why?
Yttrium Radioisotopes
1
2008
1
0.160
Why?
Bone Marrow Purging
1
2008
4
0.160
Why?
Immunoglobulin Class Switching
1
2008
17
0.160
Why?
Drugs, Investigational
1
2008
8
0.160
Why?
Breast Neoplasms
2
2002
673
0.160
Why?
Graft Survival
3
2002
148
0.160
Why?
Italy
1
2008
22
0.160
Why?
Sinusitis
1
2008
21
0.160
Why?
Chemokine CCL2
1
2009
127
0.160
Why?
Myeloid Cells
1
2008
16
0.160
Why?
Cytogenetics
1
2008
14
0.160
Why?
Antibody Formation
1
2009
179
0.160
Why?
National Cancer Institute (U.S.)
1
2008
12
0.160
Why?
Immunoglobulins, Intravenous
1
2008
36
0.160
Why?
Drug Monitoring
1
2008
41
0.160
Why?
Genes, myc
1
2008
29
0.160
Why?
Biopsy, Fine-Needle
1
2008
21
0.160
Why?
Cell Line, Tumor
4
2009
575
0.150
Why?
CD4 Lymphocyte Count
1
2008
148
0.150
Why?
HIV Seropositivity
1
2008
34
0.150
Why?
Epitopes
1
2008
202
0.150
Why?
Pyrimidines
1
2008
64
0.150
Why?
Health Status Indicators
1
2008
107
0.150
Why?
Radiotherapy Dosage
1
2008
203
0.150
Why?
Bleomycin
2
2003
47
0.150
Why?
Piperazines
1
2008
74
0.150
Why?
Drug Delivery Systems
1
2008
59
0.150
Why?
Immunocompromised Host
1
2008
83
0.150
Why?
Data Collection
1
2008
215
0.150
Why?
Gene Rearrangement
2
2002
37
0.150
Why?
In Situ Hybridization, Fluorescence
1
2008
110
0.150
Why?
Leukemia, Myeloid
1
2008
119
0.150
Why?
Introns
1
2008
111
0.150
Why?
Interferon-gamma
1
2009
348
0.150
Why?
Immunologic Memory
1
2008
119
0.150
Why?
Tumor Markers, Biological
1
2009
229
0.140
Why?
Time
1
2006
46
0.140
Why?
Liver
1
2011
877
0.140
Why?
Mice, Nude
3
2010
183
0.140
Why?
Leukemia, Myeloid, Acute
1
2008
177
0.140
Why?
Radiotherapy
1
2008
198
0.140
Why?
Hypertension
1
2009
301
0.140
Why?
Psittacosis
1
2005
2
0.140
Why?
Chlamydophila psittaci
1
2005
3
0.140
Why?
Proteins
1
2009
468
0.140
Why?
Eye Neoplasms
1
2005
20
0.130
Why?
Molecular Biology
1
2006
46
0.130
Why?
Immunohistochemistry
1
2009
1064
0.130
Why?
Brain Neoplasms
1
2008
281
0.130
Why?
Cell Division
1
2008
762
0.130
Why?
Complement C1q
1
2005
8
0.130
Why?
Hospitalization
2
1993
399
0.120
Why?
Promoter Regions, Genetic
1
2008
553
0.120
Why?
STAT1 Transcription Factor
1
2004
21
0.120
Why?
Neoplastic Cells, Circulating
1
2003
7
0.120
Why?
Iodine Radioisotopes
1
2004
100
0.120
Why?
Blood Component Removal
1
2003
11
0.120
Why?
Prospective Studies
4
2002
1689
0.110
Why?
Risk
2
2001
368
0.110
Why?
Random Allocation
1
2004
248
0.110
Why?
Magnetic Resonance Imaging
1
2009
991
0.110
Why?
Cause of Death
2
2001
162
0.110
Why?
Infusions, Intravenous
1
2003
143
0.110
Why?
Fluorine Radioisotopes
1
2003
8
0.110
Why?
Administration, Oral
1
2004
308
0.110
Why?
Schizophrenia
2
1993
130
0.110
Why?
Fluorodeoxyglucose F18
1
2003
17
0.110
Why?
Proportional Hazards Models
2
2001
450
0.110
Why?
Radiopharmaceuticals
1
2003
48
0.110
Why?
Chromosomes, Human, Pair 14
1
2002
15
0.110
Why?
Chromosomes, Human, Pair 18
1
2002
15
0.110
Why?
Antigens, CD56
1
2002
16
0.110
Why?
Eosinophils
1
2002
49
0.100
Why?
Histocompatibility
1
2002
13
0.100
Why?
Lymphoma, T-Cell
1
2002
11
0.100
Why?
Breast Implants
1
2002
13
0.100
Why?
MAP Kinase Kinase 4
2
2011
25
0.100
Why?
Pneumonectomy
1
2001
14
0.100
Why?
Pleural Effusion
1
2001
31
0.100
Why?
Positive-Pressure Respiration
1
2001
26
0.100
Why?
Analysis of Variance
2
1998
736
0.100
Why?
Epidemiologic Methods
1
2001
57
0.100
Why?
Ontario
1
2001
11
0.100
Why?
Biological Markers
1
2004
560
0.100
Why?
Lymph Node Excision
1
2001
46
0.100
Why?
Laser Therapy
1
2001
62
0.100
Why?
Tongue Neoplasms
1
1981
6
0.100
Why?
Thyroglossal Cyst
1
1981
7
0.100
Why?
Radiation-Sensitizing Agents
1
2001
75
0.100
Why?
Xenograft Model Antitumor Assays
2
2010
47
0.100
Why?
Choristoma
1
1981
22
0.100
Why?
Thyroid Gland
1
1981
54
0.100
Why?
Risk Assessment
2
1999
884
0.090
Why?
Gene Expression
1
2004
751
0.090
Why?
Reoperation
1
2001
183
0.090
Why?
Sensitivity and Specificity
1
2004
905
0.090
Why?
CD8-Positive T-Lymphocytes
1
2002
224
0.090
Why?
Octreotide
1
1999
5
0.090
Why?
Indium Radioisotopes
1
1999
4
0.090
Why?
Abdominal Neoplasms
1
1999
17
0.090
Why?
Sarcoma, Synovial
1
1999
7
0.090
Why?
Thigh
1
1999
24
0.090
Why?
Chondrosarcoma
1
1999
15
0.090
Why?
Medical Records
2
2008
124
0.090
Why?
Hematopoietic Stem Cells
1
2002
197
0.090
Why?
Karyotyping
1
1999
109
0.090
Why?
Tomography, Emission-Computed, Single-Photon
1
1999
70
0.090
Why?
Histones
2
2011
174
0.080
Why?
Liver Neoplasms
1
1999
151
0.080
Why?
Enzyme Activation
2
2009
554
0.080
Why?
Bone Neoplasms
1
1999
207
0.080
Why?
Enzyme Inhibitors
2
2009
422
0.070
Why?
Statistics, Nonparametric
1
1998
262
0.070
Why?
Lung Neoplasms
1
1999
439
0.070
Why?
Mice
3
2010
6111
0.060
Why?
Reproducibility of Results
2
2008
877
0.060
Why?
Logistic Models
2
2004
611
0.060
Why?
Respiratory Sounds
1
1994
23
0.060
Why?
Bronchoscopy
1
1994
29
0.060
Why?
Esophagoscopy
1
1994
26
0.060
Why?
Posture
1
1994
110
0.060
Why?
Leukocyte Count
1
1993
161
0.060
Why?
Patient Admission
1
1994
85
0.060
Why?
Infant, Newborn
2
1981
1844
0.060
Why?
Syndrome
1
1993
208
0.060
Why?
Catheterization
1
1994
125
0.060
Why?
Wisconsin
1
1992
8
0.050
Why?
Length of Stay
1
1994
287
0.050
Why?
Neoplasm Grading
1
2012
8
0.050
Why?
Lung
1
1999
1159
0.050
Why?
Receptors, Antigen, B-Cell
1
2012
19
0.050
Why?
bcl-2 Homologous Antagonist-Killer Protein
1
2012
5
0.050
Why?
Watchful Waiting
1
2012
2
0.050
Why?
Anthracyclines
1
2012
17
0.050
Why?
Apoptosis Regulatory Proteins
1
2012
25
0.050
Why?
bcl-2-Associated X Protein
1
2012
56
0.050
Why?
Drug Evaluation
1
2011
101
0.050
Why?
Cell Cycle Checkpoints
1
2011
4
0.050
Why?
Oncogene Protein v-akt
1
2011
5
0.050
Why?
Injections, Intra-Arterial
1
2011
31
0.050
Why?
Sex Factors
1
1993
597
0.050
Why?
Histone Deacetylases
1
2012
71
0.050
Why?
Protein Kinases
1
2012
113
0.050
Why?
History, 20th Century
1
1992
244
0.050
Why?
Proto-Oncogene Proteins c-akt
1
2012
128
0.050
Why?
Superoxide Dismutase
1
2011
74
0.050
Why?
Population Surveillance
1
2012
136
0.050
Why?
Leukopenia
1
2010
24
0.050
Why?
Diagnosis, Differential
1
1994
874
0.050
Why?
Caspases
1
2011
101
0.050
Why?
Reed-Sternberg Cells
1
2010
5
0.050
Why?
Microdissection
1
2010
8
0.050
Why?
Paraffin Embedding
1
2010
14
0.050
Why?
Formaldehyde
1
2010
24
0.050
Why?
Tissue Fixation
1
2010
18
0.050
Why?
Disease Management
1
2010
26
0.050
Why?
Chymotrypsin
1
2010
8
0.050
Why?
Multicenter Studies as Topic
1
2010
129
0.050
Why?
Anemia
1
2010
78
0.050
Why?
Benzenesulfonates
1
2010
7
0.050
Why?
DNA, Neoplasm
1
2010
128
0.050
Why?
Benzamides
1
2010
19
0.050
Why?
Calcifediol
1
2009
6
0.040
Why?
Dihydroxycholecalciferols
1
2009
9
0.040
Why?
Clone Cells
1
2010
186
0.040
Why?
Animals
3
2010
16093
0.040
Why?
Societies, Medical
1
2011
138
0.040
Why?
Nutrition Policy
1
2009
11
0.040
Why?
Seasons
1
2009
97
0.040
Why?
Proto-Oncogene Proteins
1
2012
289
0.040
Why?
Dietary Supplements
1
2009
44
0.040
Why?
Nausea
1
2010
155
0.040
Why?
Lymphoproliferative Disorders
1
2009
30
0.040
Why?
Physician's Practice Patterns
1
2012
243
0.040
Why?
DNA Damage
1
2010
170
0.040
Why?
Protein Binding
1
2012
827
0.040
Why?
Cladribine
1
2008
6
0.040
Why?
Blast Crisis
1
2008
18
0.040
Why?
Immunity, Cellular
1
2009
132
0.040
Why?
Cell Cycle
1
2010
254
0.040
Why?
Phosphorylation
1
2011
774
0.040
Why?
Granulocyte Colony-Stimulating Factor
1
2008
44
0.040
Why?
Observer Variation
1
2008
144
0.040
Why?
Multivariate Analysis
1
2010
541
0.040
Why?
Case-Control Studies
1
2010
617
0.040
Why?
Membrane Proteins
1
2012
540
0.040
Why?
Evidence-Based Medicine
1
2009
202
0.040
Why?
Tomography, X-Ray Computed
1
2012
759
0.040
Why?
Blotting, Western
1
2010
645
0.040
Why?
Antibodies, Anti-Idiotypic
1
2007
51
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
542
0.040
Why?
Dacarbazine
1
2007
21
0.040
Why?
Polyethylene Glycols
1
2007
56
0.040
Why?
Severity of Illness Index
1
2011
922
0.040
Why?
Bone Marrow
1
2008
287
0.040
Why?
Mitochondria
1
2010
340
0.040
Why?
Transfection
1
2010
859
0.030
Why?
Neutropenia
1
2007
67
0.030
Why?
Thrombocytopenia
1
2007
74
0.030
Why?
NF-kappa B
1
2010
432
0.030
Why?
DNA, Bacterial
1
2005
173
0.030
Why?
Prednisolone
1
2004
24
0.030
Why?
Radiation-Protective Agents
1
2004
41
0.030
Why?
Cytokines
1
2007
565
0.030
Why?
Chi-Square Distribution
1
2004
344
0.030
Why?
Bone Marrow Cells
1
2004
221
0.030
Why?
Radiotherapy, High-Energy
1
2002
24
0.030
Why?
Silicone Gels
1
2002
10
0.030
Why?
Dose-Response Relationship, Radiation
1
2002
219
0.030
Why?
Hematopoietic Stem Cell Mobilization
1
2002
14
0.030
Why?
Microspheres
1
2002
56
0.030
Why?
Tissue Donors
1
2002
69
0.030
Why?
Antigens, Differentiation, B-Lymphocyte
1
2002
51
0.020
Why?
Hyoid Bone
1
1981
5
0.020
Why?
Mediastinal Neoplasms
1
1981
21
0.020
Why?
Survivors
1
2002
118
0.020
Why?
Pilot Projects
1
2002
442
0.020
Why?

Visualizations


Friedberg's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department